2025-12-31 - Analysis Report
Okay, here's a comprehensive analysis of BlackRock (BLK) based on the provided data.

**0) Basic Numbers & Data Presentation:**

Here's a breakdown of the information.

**1) Return Rate Comparison:**

*   **Ticker:** BLK
*   **Company:** BlackRock Inc. - The world's largest asset manager.
*   **BLK Cumulative Return:** 57.8998%
*   **VOO (S&P 500) Cumulative Return:** 102.2134%
*   **Divergence (BLK - VOO):**
    *   Current: -44.6%
    *   Min: -49.6%
    *   Max: 32.1%
    *   Relative Divergence: 6.1%

**Analysis:**

*   BlackRock has significantly underperformed the S&P 500 (VOO) over the analyzed period. The current divergence is -44.6%, indicating a substantial difference in cumulative returns.
*   The relative divergence of 6.1% suggests the current divergence is near the low end of its historical range. This *could* mean that BlackRock is currently undervalued compared to the S&P 500 based on past performance, but it doesn't guarantee future outperformance.

**Alpha, Beta, and Related Metrics:**

| Year       | CAGR  | MDD  | Alpha  | Beta  | Cap(B)  |
|------------|-------|-------|--------|-------|---------|
| 2015-2017  | 48.0% | 61.2% | 20.0%  | 0.1   | 79.7    |
| 2016-2018  | 7.0%  | 68.1% | -8.0%  | 0.1   | 61.0    |
| 2017-2019  | 18.0% | 69.4% | -5.0%  | -0.4  | 78.0    |
| 2018-2020  | -2.0% | 81.8% | -25.0% | -0.3  | 112.0   |
| 2019-2021  | 67.0% | 81.8% | 20.0%  | -0.2  | 142.1   |
| 2020-2022  | -2.0% | 81.8% | -1.0%  | 2.2   | 109.9   |
| 2021-2023  | 6.0%  | 76.8% | 4.0%   | 3.0   | 126.0   |
| 2022-2024  | 24.0% | 78.6% | 3.0%   | 3.1   | 159.1   |
| 2023-2025  | 23.0% | 78.6% | -43.0% | 1.3   | 168.1   |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  Growth rates fluctuate significantly over the periods, ranging from negative to very positive.
*   **MDD (Maximum Drawdown):**  MDD is consistently high, indicating significant potential for losses during downturns.
*   **Alpha:**  Alpha is inconsistent, showing periods of outperformance (positive Alpha) and underperformance (negative Alpha) relative to its benchmark.  The recent -43% Alpha for 2023-2025 is concerning.
*   **Beta:** Beta varies, in some periods being negative (moving opposite the benchmark), and in others significantly above 1.0 (more volatile than the benchmark). A high positive beta in recent years indicates that BLK's price is now more strongly correlated and more sensitive to market movements.
*   **Cap(B) (Market Cap in Billions):**  Market capitalization has generally increased, reflecting overall growth in the company.

**2) Recent Stock Price Fluctuations:**

*   **Current Price:** 1083.31
*   **Previous Close:** 1088.4
*   **Change:** -0.47%
*   **5-day SMA:** 1087.066
*   **20-day SMA:** 1074.8612
*   **60-day SMA:** 1091.6603

**Analysis:**

*   The stock price experienced a small decrease in the last trading session.
*   The 5-day SMA is above the 20-day SMA, suggesting a short-term upward trend.  However, both are fluctuating below the 60-day SMA, indicating a possible weakening or consolidation of the upward trend.

**3) Technical Indicators and Expected Return:**

*   **MRI (Market Risk Indicator):** 0.9 (High Investment Recommended)
*   **RSI (Relative Strength Index):** 58.88 (Neutral - neither overbought nor oversold)
*   **PPO (Percentage Price Oscillator):** 0.2527 (Positive, suggesting a slight upward momentum)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80) Dividend_5.21 (Cash Ratio: 0% on 2025-12-05)
*   **Recent (20 days) relative divergence change:** -0.9 (Negative - short-term decline)
*   **Expected Return (%):** -139.2% (Very Negative - Expected underperformance vs current price)

**Analysis:**

*   The MRI suggests a high investment recommendation, which contradicts the negative expected return and relative divergence. The MRI might be based on a longer-term outlook or different factors than the short-term indicators.
*   The RSI is neutral.
*   The PPO shows slight upward momentum.
*   The hybrid signal recommends a moderate buy using most available cash, factoring in dividend income.
*   The negative change in relative divergence over the last 20 days suggests recent underperformance.
*   The extremely negative expected return (-139.2%) is a major red flag. This suggests the model anticipates significant underperformance compared to the S&P 500 if held long-term.

**4) Recent News & Significant Events:**

*   **ts2.tech (Dec 30, 2025):** BlackRock stock barely higher as Wall Street slips; Fed minutes and data loom. This suggests BLK is not outperforming in a down market.
*   **EBC Financial Group (Dec 24, 2025):**  Who Owns BlackRock Stock? A Guide To BLK Stock. This is general information and doesn't directly impact short-term analysis.
*   **MarketBeat (Dec 28, 2025):** Pacer Advisors Inc. Trims Stock Holdings in BlackRock $BLK.  This indicates institutional selling pressure, which could be a negative signal.
*   **Yahoo Finance (Dec 15, 2025):** Taking Stock of BlackRock (BLK): Is the Asset Manager Quietly Undervalued After Modest Recent Gains? This highlights a potential debate about BLK's valuation.
*   **The Motley Fool (Sep 14, 2025):** Here's How Many Shares of BlackRock (BLK) Stock You Should Own to Get $1,000 in Yearly Dividends. This is dividend-focused and not directly related to short-term price movements, but highlights dividend income.
*   **Stock Traders Daily (Dec 28, 2025):** The Technical Signals Behind (BLK) That Institutions Follow. Focuses on the technical aspects of BlackRock's stock, indicating increased volatility.

**Analysis:**

*   The news is mixed. Some articles suggest potential undervaluation, while others indicate institutional selling and underperformance in a weak market. This creates uncertainty.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean = 1.71)
*   **Opinions:** 15
*   **Target Price:**
    *   Avg: 1319.33
    *   High: 1514.00
    *   Low: 1170.00

**Analysis:**

*   The analyst consensus is positive, with a "Buy" recommendation and significant upside potential based on the average and high target prices. However, the wide range between the high and low target prices suggests considerable disagreement among analysts.

**5) Recent Earnings Analysis:**

| 날짜       | EPS   | 매출        |
|------------|-------|-------------|
| 2024-08-06 | 10.07 | 4.80 B$     |
| 2024-05-07 | 10.58 | 4.73 B$     |
| 2023-11-06 | 10.75 | 4.52 B$     |
| 2023-08-04 | 9.13  | 4.46 B$     |
| 2024-08-06 | 9.13  | 4.46 B$     |

**Analysis:**

*   The most recent EPS figures show fluctuating profitability.
*   Revenues have generally been increasing, but not consistently, showing signs of inconsistent growth.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|----------|---------------|
| 2025-09-30 | $6.51B  | 45.94%        |
| 2025-06-30 | $5.42B  | 47.87%        |
| 2025-03-31 | $5.28B  | 47.88%        |
| 2024-12-31 | $5.68B  | 49.25%        |
| 2024-09-30 | $5.20B  | 51.13%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE   |
|------------|-----------|-------|
| 2025-09-30 | $55.52B  | 2.38% |
| 2025-06-30 | $49.14B  | 3.24% |
| 2025-03-31 | $48.04B  | 3.14% |
| 2024-12-31 | $47.49B  | 3.52% |
| 2024-09-30 | $41.18B  | 3.96% |

**Analysis:**

*   Revenue shows a slight increase overall.
*   Profit margin decreased in recent quarters.
*   Equity has increased, indicating stronger asset base.
*   ROE (Return on Equity) decreased recently, reflecting reduced profitability relative to equity.

**7) Comprehensive Analysis (Summary):**

BlackRock presents a mixed picture.

*   **Underperformance:**  It has significantly underperformed the S&P 500 in the past.
*   **Technical Indicators:** Short-term technical indicators are neutral to slightly positive, but the very negative expected return is a major concern.
*   **News:** The news flow is mixed.
*   **Analyst Sentiment:** Analysts are generally positive, but with a wide range of target prices.
*   **Financials:** Revenue is increasing, but profitability (profit margin, ROE) is showing signs of recent decline.
*   **Risk:** High MDD shows a high risk.
*   **Alpha/Beta Fluctuation:**  Inconsistent Alpha and fluctuating Beta increase volatility.

**Overall Recommendation:**

Based on this data, a **cautious approach** is warranted. The negative expected return significantly outweighs the positive analyst consensus and MRI indicator. The recent underperformance, declining profitability metrics, and institutional selling suggest potential headwinds for BlackRock.

*   **Avoid:** Given the -139.2% expected rate of return, it may be wise to avoid investing in BLK unless further analysis explains this dramatic figure and suggests a potential catalyst for future outperformance.

**Disclaimer:**  This analysis is based solely on the provided data and should not be considered financial advice. Further research is recommended before making any investment decisions.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.